These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2526239)

  • 21. The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
    Meng YX; Jiang HY; Lu FY
    Thromb Haemost; 1990 Dec; 64(4):548-9. PubMed ID: 2084940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a combined oestrogen-progestogen injectable contraceptive.
    Bloch B; Davies AH
    S Afr Med J; 1978 May; 53(21):846-7. PubMed ID: 694639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depo-provera: injectable contraceptive?
    Moss HC
    J Indiana State Med Assoc; 1982 Aug; 75(8):530-1. PubMed ID: 6214593
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contraception with injectable long-acting preparation depo-provera].
    Prilepskaia VN; Kondrikov NI; Tagieva TT
    Akush Ginekol (Mosk); 1995; (3):7-10. PubMed ID: 7653732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding contraceptive choices: lunelle monthly contraceptive injection.
    Shulman LP
    Int J Fertil Womens Med; 2000; 45(2):190-4. PubMed ID: 10831189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    Balogun OR; Raji HO
    Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report.
    von Kesseru E; Aydinlik S; Etchepareborda JJ
    Contraception; 1994 Oct; 50(4):329-37. PubMed ID: 7813221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An introductory clinical trial of three-monthly injectable contraceptive-depot medroxyprogesterone acetate].
    Shao Q; Jiang H; Fu W
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jan; 34(1):36-9. PubMed ID: 11263172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a long-acting injectable contraceptive in a postpartum family planning program.
    Mcdaniel EB; Pardthaisong T
    Asian J Med; 1973 Apr; 9(4):133-5. PubMed ID: 12262537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A field study of Depo-Provera: its use as a contraceptive method by women in a rural town in West Malaysia from February 1968 to December 1969.
    Hew Wai Sin ; Peng JY; Dato Ariffin Marzuki
    Med J Malaysia; 1973 Jun; 27(4):299-305. PubMed ID: 4270790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
    East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
    Giwa-Osagie OF
    Contraception; 1994 May; 49(5):421-33. PubMed ID: 8045129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of injectable contraceptives in Mexican women].
    Garza-Flores J; Rodríguez V; Cravioto MC; del Real Mora O; Anderson J; Landeros J; Díaz Sánchez V; Lichtenberg R; Pérez-Palacios G
    Bol Oficina Sanit Panam; 1985 Feb; 98(2):181-6. PubMed ID: 3156612
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
    Bahamondes L; Juliato CT; Villarreal M; Sobreira-Lima B; Simões JA; dos Santos Fernandes AM
    Contraception; 2006 Sep; 74(3):259-63. PubMed ID: 16904421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Injectable contraceptives. 10 years' clinical experience].
    Cervantes A; Gorodovsky J; Maqueo M
    Ginecol Obstet Mex; 1973 Oct; 34(204):369-81. PubMed ID: 4272910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A Czechoslovak injection-contraceptive agent administered once a month].
    Stĕrba R
    Zentralbl Gynakol; 1976; 98(3):158-60. PubMed ID: 970015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
    Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of injectable formulations of contraceptive steroids in obese and thin women.
    Fotherby K; Koetsawang S
    Contraception; 1982 Jul; 26(1):51-8. PubMed ID: 7128134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.